» Articles » PMID: 29292391

HLA Variation and Disease

Overview
Journal Nat Rev Immunol
Date 2018 Jan 3
PMID 29292391
Citations 321
Authors
Affiliations
Soon will be listed here.
Abstract

Fifty years since the first description of an association between HLA and human disease, HLA molecules have proven to be central to physiology, protective immunity and deleterious, disease-causing autoimmune reactivity. Technological advances have enabled pivotal progress in the determination of the molecular mechanisms that underpin the association between HLA genetics and functional outcome. Here, we review our current understanding of HLA molecules as the fundamental platform for immune surveillance and responsiveness in health and disease. We evaluate the scope for personalized antigen-specific disease prevention, whereby harnessing HLA-ligand interactions for clinical benefit is becoming a realistic prospect.

Citing Articles

Comprehensive causal analysis between autoimmune diseases and glioma: A Mendelian randomization study.

Deng N, Agila R, He Q, You C, Zheng S Medicine (Baltimore). 2025; 104(10):e41815.

PMID: 40068088 PMC: 11902947. DOI: 10.1097/MD.0000000000041815.


Immunogenetics of longevity and its association with human endogenous retrovirus K.

James L, Georgopoulos A Front Aging. 2025; 6:1471202.

PMID: 39967996 PMC: 11832543. DOI: 10.3389/fragi.2025.1471202.


Immune Tolerance Regulation Is Critical to Immune Homeostasis.

Han L, Wu T, Zhang Q, Qi A, Zhou X J Immunol Res. 2025; 2025:5006201.

PMID: 39950084 PMC: 11824399. DOI: 10.1155/jimr/5006201.


The Limitation of HLA Diversity as a Risk Factor for Pediatric-Onset Autoimmune Rheumatic Disease.

Kalampokis I, Wong C, Ma J, Smith L, Masten B, Chabot-Richards D J Clin Med. 2025; 14(3).

PMID: 39941587 PMC: 11818087. DOI: 10.3390/jcm14030916.


Human immune system: Exploring diversity across individuals and populations.

Hoang Nguyen K, Le N, Nguyen P, Nguyen H, Hoang D, Huynh C Heliyon. 2025; 11(2):e41836.

PMID: 39911431 PMC: 11795082. DOI: 10.1016/j.heliyon.2025.e41836.


References
1.
Robinson J, Soormally A, Hayhurst J, Marsh S . The IPD-IMGT/HLA Database - New developments in reporting HLA variation. Hum Immunol. 2016; 77(3):233-237. DOI: 10.1016/j.humimm.2016.01.020. View

2.
Lang H, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L . A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol. 2002; 3(10):940-3. DOI: 10.1038/ni835. View

3.
Zernich D, Purcell A, Macdonald W, Kjer-Nielsen L, Ely L, Laham N . Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med. 2004; 200(1):13-24. PMC: 2213310. DOI: 10.1084/jem.20031680. View

4.
Shrestha D, Szollosi J, Jenei A . Bare lymphocyte syndrome: an opportunity to discover our immune system. Immunol Lett. 2011; 141(2):147-57. DOI: 10.1016/j.imlet.2011.10.007. View

5.
Williams A, Peh C, Purcell A, McCluskey J, Elliott T . Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity. 2002; 16(4):509-20. DOI: 10.1016/s1074-7613(02)00304-7. View